Brain Injury Derived Neurotrophic Peptide
CAS No. 148330-12-5
Brain Injury Derived Neurotrophic Peptide( ——— )
Catalog No. M42153 CAS No. 148330-12-5
Brain Injury Derived Neurotrophic Peptide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBrain Injury Derived Neurotrophic Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrain Injury Derived Neurotrophic Peptide
-
DescriptionBrain Injury Derived Neurotrophic Peptide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number148330-12-5
-
Formula Weight1387.61
-
Molecular FormulaC62H102N18O18
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Polistes Mastoparan
Polistes mastoparan is an antimicrobial peptide. Polistes mastoparan increases S. aureus cell K+ efflux and inhibits cell viability with EC50 of 5 μM.
-
Opromazine hydrochlo...
Opromazine hydrochloride is a compound used as a molecular building block.
-
SR11237
SR11237 is a Pan retinoid X receptor (RXR) agonist. SR11237 causes RXR/RXR homodimers to form and transactivate a reporter gene containing a RXR-response element.
Cart
sales@molnova.com